Ancell

anti-CD155 [PVR] (human), mAb (ANC6A3) (FITC)

CHF 423.00

In stock

ANC-350-040120 testsCHF 423.00

More Information
Product Details
Synonyms	PVR; Polio Virus Receptor
Product Type	Monoclonal Antibody
Properties
Clone	ANC6A3
Isotype	Mouse IgG1κ
Immunogen/Antigen	Recombinant human CD155.
Label/Conjugates	FITC
Application	ELISA FACS
Crossreactivity	Human
Purity	≥95% (SDS-PAGE)
Purity Detail	Protein A purified.
Concentration	1mg/ml
Formulation	50mM Sodium Phosphate pH 7.5, 100mM Potassium Chloride, 150mM NaCl, 5% glycerol, 0.2% BSA, 0.04% NaN₃.
Isotype Negative Control	Mouse IgG1 Isotype Control (FITC)
Other Product Data	Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet.
Declaration	Manufactured by Ancell Corporation.
Shipping and Handling
Shipping	BLUE ICE
Short Term Storage	+4°C
Long Term Storage	+4°C
Handling Advice	Avoid freeze/thaw cycles. Protect from light.
Use/Stability	Stable for at least 1 year after receipt when stored at +4°C.
Documents
MSDS	Inquire
Product Specification Sheet
Datasheet	Download PDF

Product-specific References

Description

Human CD155 (Polio Virus Receptor, PVR, Necl-5) is a 70 kd type I Ig superfamily molecule. It is involved in formation of intracellular junctions between epithelial cells. Its ligands include CD226 (DNAM-1), and CD96 (TACTILE). CD155 expression by tumor has been shown to be upregulated by nitric oxide. A soluble version of CD155 has been shown to exist. High CD155 expression has recently been exploited to use engineered poliovirus to treat glioblastoma.

Call	+41 61 926 6040
Fax	+41 61 926 6049